DK2069528T3 - Fremgangsmåde til diagnosticering af atherosklerotiske plaques ved måling af CD36 - Google Patents
Fremgangsmåde til diagnosticering af atherosklerotiske plaques ved måling af CD36Info
- Publication number
- DK2069528T3 DK2069528T3 DK08700920.5T DK08700920T DK2069528T3 DK 2069528 T3 DK2069528 T3 DK 2069528T3 DK 08700920 T DK08700920 T DK 08700920T DK 2069528 T3 DK2069528 T3 DK 2069528T3
- Authority
- DK
- Denmark
- Prior art keywords
- measuring
- atherosclerotic plaques
- diagnosing atherosclerotic
- diagnosing
- plaques
- Prior art date
Links
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
- G01N33/6893—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
- C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/543—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/106—Pharmacogenomics, i.e. genetic variability in individual responses to drugs and drug metabolism
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/158—Expression markers
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
- G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
- G01N2333/705—Assays involving receptors, cell surface antigens or cell surface determinants
- G01N2333/70596—Molecules with a "CD"-designation not provided for elsewhere in G01N2333/705
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2800/00—Detection or diagnosis of diseases
- G01N2800/32—Cardiovascular disorders
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2800/00—Detection or diagnosis of diseases
- G01N2800/32—Cardiovascular disorders
- G01N2800/323—Arteriosclerosis, Stenosis
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2800/00—Detection or diagnosis of diseases
- G01N2800/50—Determining the risk of developing a disease
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2800/00—Detection or diagnosis of diseases
- G01N2800/52—Predicting or monitoring the response to treatment, e.g. for selection of therapy based on assay results in personalised medicine; Prognosis
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2800/00—Detection or diagnosis of diseases
- G01N2800/56—Staging of a disease; Further complications associated with the disease
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Immunology (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Analytical Chemistry (AREA)
- Hematology (AREA)
- Urology & Nephrology (AREA)
- Biomedical Technology (AREA)
- Organic Chemistry (AREA)
- Microbiology (AREA)
- Biotechnology (AREA)
- Physics & Mathematics (AREA)
- Biochemistry (AREA)
- General Health & Medical Sciences (AREA)
- Pathology (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Genetics & Genomics (AREA)
- Medicinal Chemistry (AREA)
- General Physics & Mathematics (AREA)
- Food Science & Technology (AREA)
- Cell Biology (AREA)
- Biophysics (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Engineering & Computer Science (AREA)
- Peptides Or Proteins (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Investigating Or Analysing Biological Materials (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DKPA200700192 | 2007-02-05 | ||
| PCT/DK2008/000049 WO2008095492A2 (en) | 2007-02-05 | 2008-02-04 | A method for diagnosing atherosclerotic plaques by measurement of cd36 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DK2069528T3 true DK2069528T3 (da) | 2013-05-21 |
Family
ID=39579960
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DK08700920.5T DK2069528T3 (da) | 2007-02-05 | 2008-02-04 | Fremgangsmåde til diagnosticering af atherosklerotiske plaques ved måling af CD36 |
Country Status (8)
| Country | Link |
|---|---|
| US (4) | US20100105088A1 (da) |
| EP (1) | EP2069528B1 (da) |
| CN (1) | CN101627135B (da) |
| AU (1) | AU2008213472A1 (da) |
| CA (1) | CA2712834A1 (da) |
| DK (1) | DK2069528T3 (da) |
| ES (1) | ES2415375T3 (da) |
| WO (1) | WO2008095492A2 (da) |
Families Citing this family (33)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DK2069528T3 (da) * | 2007-02-05 | 2013-05-21 | Region Nordjylland | Fremgangsmåde til diagnosticering af atherosklerotiske plaques ved måling af CD36 |
| WO2011063470A1 (en) | 2009-11-27 | 2011-06-03 | Baker Idi Heart And Diabetes Institute Holdings Limited | Lipid biomarkers for stable and unstable heart disease |
| WO2012058269A2 (en) | 2010-10-29 | 2012-05-03 | The United States Of America, As Represented By The Secretary, Department Of Health And Human Services | Methods of treating cancer and other diseases |
| WO2012149465A2 (en) * | 2011-04-27 | 2012-11-01 | Isis Pharmaceuticals, Inc. | Modulation of cd36 expression |
| US10779855B2 (en) | 2011-08-05 | 2020-09-22 | Route 92 Medical, Inc. | Methods and systems for treatment of acute ischemic stroke |
| EP2739217B1 (en) | 2011-08-05 | 2022-07-20 | Route 92 Medical, Inc. | Systems for treatment of acute ischemic stroke |
| EP2839292A4 (en) * | 2012-04-19 | 2015-08-26 | Univ California | COMPOSITIONS AND METHODS FOR DETECTING INSTABLIC ARTERIOSCLEOTIC PLAQUE |
| US9265512B2 (en) | 2013-12-23 | 2016-02-23 | Silk Road Medical, Inc. | Transcarotid neurovascular catheter |
| US11065019B1 (en) | 2015-02-04 | 2021-07-20 | Route 92 Medical, Inc. | Aspiration catheter systems and methods of use |
| CA2983072A1 (en) | 2015-02-04 | 2016-08-11 | Route 92 Medical, Inc. | Rapid aspiration thrombectomy system and method |
| WO2017019563A1 (en) | 2015-07-24 | 2017-02-02 | Route 92 Medical, Inc. | Anchoring delivery system and methods |
| US10716915B2 (en) | 2015-11-23 | 2020-07-21 | Mivi Neuroscience, Inc. | Catheter systems for applying effective suction in remote vessels and thrombectomy procedures facilitated by catheter systems |
| JP7012655B2 (ja) | 2016-02-24 | 2022-01-28 | インセプト、リミテッド、ライアビリティ、カンパニー | 可撓性の強化された神経血管カテーテル |
| EP3565511B1 (en) | 2017-01-06 | 2023-10-18 | Incept, LLC | Thromboresistant coatings for aneurysm treatment devices |
| EP4134120A1 (en) | 2017-01-10 | 2023-02-15 | Route 92 Medical, Inc. | Aspiration catheter systems |
| US10864350B2 (en) | 2017-01-20 | 2020-12-15 | Route 92 Medical, Inc. | Single operator intracranial medical device delivery systems and methods of use |
| US20200131576A1 (en) * | 2017-04-25 | 2020-04-30 | The Brigham And Women's Hospital, Inc. | IL-8, IL-6, IL-1 Beta and TET2 and DNMT3A in Atherosclerosis |
| EP3787523A4 (en) | 2018-05-01 | 2022-02-23 | Incept, LLC | DEVICES AND METHODS FOR REMOVAL OF OBSTRUCTIVE MATERIAL FROM AN INTRAVASCULAR SITE |
| US11395665B2 (en) | 2018-05-01 | 2022-07-26 | Incept, Llc | Devices and methods for removing obstructive material, from an intravascular site |
| CN115999019B (zh) | 2018-05-17 | 2025-05-27 | 92号医疗公司 | 抽吸导管系统和使用方法 |
| US11471582B2 (en) | 2018-07-06 | 2022-10-18 | Incept, Llc | Vacuum transfer tool for extendable catheter |
| WO2020010310A1 (en) | 2018-07-06 | 2020-01-09 | Imperative Care, Inc. | Sealed neurovascular extendable catheter |
| US11766539B2 (en) | 2019-03-29 | 2023-09-26 | Incept, Llc | Enhanced flexibility neurovascular catheter |
| WO2021076642A1 (en) | 2019-10-15 | 2021-04-22 | Imperative Care, Inc. | Systems and methods for multivariate stroke detection |
| EP4076611A4 (en) | 2019-12-18 | 2023-11-15 | Imperative Care, Inc. | Methods and systems for treating venous thromboembolic disease |
| US11439799B2 (en) | 2019-12-18 | 2022-09-13 | Imperative Care, Inc. | Split dilator aspiration system |
| US11638637B2 (en) | 2019-12-18 | 2023-05-02 | Imperative Care, Inc. | Method of removing embolic material with thrombus engagement tool |
| CN118925025A (zh) | 2020-03-10 | 2024-11-12 | 因普瑞缇夫护理公司 | 增强的柔韧性的神经血管导管 |
| US11207497B1 (en) | 2020-08-11 | 2021-12-28 | Imperative Care, Inc. | Catheter with enhanced tensile strength |
| US12582802B2 (en) | 2020-10-09 | 2026-03-24 | Route 92 Medical, Inc. | Aspiration catheter systems and methods of use |
| US12558175B2 (en) | 2021-08-12 | 2026-02-24 | Imperative Care, Inc. | Multi catheter method of performing a robotic neurovascular procedure |
| CN114230632B (zh) * | 2021-09-18 | 2023-01-24 | 华南农业大学 | 一种丙烯酰胺衍生物模拟表位肽及应用 |
| USD1077996S1 (en) | 2021-10-18 | 2025-06-03 | Imperative Care, Inc. | Inline fluid filter |
Family Cites Families (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB9306053D0 (en) * | 1993-03-24 | 1993-05-12 | Nycomed Pharma As | Method and assay |
| EP2305235A1 (en) * | 1997-04-02 | 2011-04-06 | The Brigham And Women's Hospital, Inc. | Means of ascertaining an individual's risk profile for atherosclerotic disease |
| US20030219821A1 (en) * | 1998-02-13 | 2003-11-27 | Fisher Paul B. | Methods for identifying oncogenes and tumor-associated proteins |
| JP2000180447A (ja) * | 1998-12-11 | 2000-06-30 | Dainippon Pharmaceut Co Ltd | 急性心筋梗塞の判定方法及び判定用試薬 |
| JP2001056338A (ja) * | 1999-08-19 | 2001-02-27 | Tokyoto Igaku Kenkyu Kiko | 経皮的冠動脈形成術後の冠動脈再狭窄の可能性を検出する方法 |
| US6812023B1 (en) * | 2000-04-27 | 2004-11-02 | Anosys, Inc. | Methods of producing membrane vesicles |
| AU2003259340A1 (en) * | 2002-08-23 | 2004-03-11 | Gestion Univalor Societe En Commandite | Growth hormone-releasing peptides in the treatment of prevention of atherosclerosis and hypercholesterolemia |
| US20040076621A1 (en) * | 2002-10-16 | 2004-04-22 | Isis Pharmaceuticals Inc. | Antisense modulation of CD36 expression |
| EP1431399A1 (en) * | 2002-12-20 | 2004-06-23 | Clinigenetics | Methods and composition for identifying therapeutic agents of atherosclerotic plaque lesions |
| US20050032117A1 (en) * | 2003-02-14 | 2005-02-10 | Seikagaku Corporation | Method for assessment of cystic lung fibrosis |
| WO2005117859A2 (en) * | 2004-05-11 | 2005-12-15 | Joslin Diabetes Center, Inc. | Methods of diagnosing cardiovascular disease |
| BRPI0511489B8 (pt) * | 2004-05-26 | 2016-12-20 | Aase Handberg | método de avaliação do risco relativo de desenvolver aterosclerose em pacientes |
| DK2069528T3 (da) * | 2007-02-05 | 2013-05-21 | Region Nordjylland | Fremgangsmåde til diagnosticering af atherosklerotiske plaques ved måling af CD36 |
-
2008
- 2008-02-04 DK DK08700920.5T patent/DK2069528T3/da active
- 2008-02-04 US US12/525,887 patent/US20100105088A1/en not_active Abandoned
- 2008-02-04 AU AU2008213472A patent/AU2008213472A1/en not_active Abandoned
- 2008-02-04 CN CN2008800041057A patent/CN101627135B/zh not_active Expired - Fee Related
- 2008-02-04 WO PCT/DK2008/000049 patent/WO2008095492A2/en not_active Ceased
- 2008-02-04 CA CA2712834A patent/CA2712834A1/en not_active Abandoned
- 2008-02-04 ES ES08700920T patent/ES2415375T3/es active Active
- 2008-02-04 EP EP08700920A patent/EP2069528B1/en active Active
-
2010
- 2010-12-17 US US12/971,715 patent/US20110212471A1/en not_active Abandoned
-
2014
- 2014-06-26 US US14/316,521 patent/US20140371089A1/en not_active Abandoned
-
2016
- 2016-01-26 US US15/006,719 patent/US20160377632A1/en not_active Abandoned
Also Published As
| Publication number | Publication date |
|---|---|
| US20140371089A1 (en) | 2014-12-18 |
| US20100105088A1 (en) | 2010-04-29 |
| WO2008095492A2 (en) | 2008-08-14 |
| EP2069528A2 (en) | 2009-06-17 |
| US20160377632A1 (en) | 2016-12-29 |
| WO2008095492A3 (en) | 2008-10-02 |
| AU2008213472A1 (en) | 2008-08-14 |
| EP2069528B1 (en) | 2013-03-27 |
| CN101627135A (zh) | 2010-01-13 |
| ES2415375T3 (es) | 2013-07-25 |
| CA2712834A1 (en) | 2008-08-14 |
| CN101627135B (zh) | 2013-04-10 |
| US20110212471A1 (en) | 2011-09-01 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DK2157903T3 (da) | Fremgangsmåde til iagttagelsesmåling | |
| EP2215261A4 (en) | METHOD FOR DIAGNOSING TUMOR DISEASES | |
| IL211217A0 (en) | Methods for evaluating chromatography column performance | |
| DK2050765T3 (da) | Fremgangsmåder til anvendelse ved til mennesker tilpassede antistoffer | |
| EP2296813C0 (en) | INTEGRATED ANALYTIC DEVICES | |
| EP2190629A4 (en) | REST MOMENT ANALYSIS DEVICE | |
| EP2009611A4 (en) | ROAD SHARING LINE DETECTOR | |
| NO20080454L (no) | Anordning ved turbinmontasje | |
| EP2116827A4 (en) | SPECTROSCOPE | |
| DK2313364T3 (da) | Fremgangsmåder til detektering af symmetrisk demethylarginin | |
| FI20080493A0 (fi) | Menetelmä hiilinielun mittaamiseksi | |
| DK3106875T3 (da) | Fremgangsmåde til detektering af cancer | |
| PL2254850T3 (pl) | Sposób jodowania związków aromatycznych | |
| BRPI0907122A2 (pt) | Piridoindóis (1-azinona) substituídos | |
| IL212622A0 (en) | Biomarkers for assessing atherosclerotic potential | |
| EP1990627A4 (en) | METHOD FOR ANALYZING AN OPTICAL MEASUREMENT | |
| FI20085283A7 (fi) | Menetelmä kaasujen mittaamiseksi | |
| AT505325A3 (de) | Prüfstand | |
| DK2367562T3 (da) | Glycanspecifikke analyseværktøjer | |
| DK2272538T3 (da) | Fremgangsmåde til påvisning af blærecancer | |
| FI20095206A0 (fi) | Menetelmä mittaukseen höyrystyspinnalta | |
| NO20081652L (no) | Anordning ved renseverktoy | |
| FI20075954L (fi) | Menetelmä orgaanisen pigmentin valmistamiseksi | |
| DE602006006115D1 (de) | Fixierungsvorrichtung für Fahrradnabe | |
| DK2318809T3 (da) | Enhed til fjernmåling |